Search or
𝛼SK
𝛼SKbullish
Zai Lab IPO: Experienced Team, Promising In-Licensing Drug Pipeline (Part 1)
1.6k Views13 Sep 2017 06:32
Zai Lab is looking to raise US$100m in the US listing. The company has a short history of three years and does not have a commercial product at the...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 8-minute read)
Related Insights
More »- [Zai LAB (ZLAB US, BUY, TP US$40) Review]: Past Is Holding ZLAB Back but Future Is What Matters
- ZaiLab's DLL3 ADC Is a Major Positive, but the Market Over-Reacted to Its Prospects
- [Zai LAB (ZLAB US, SELL, TP US$20) TP Change]: Two Positive News Drove up 2024 Growth Target
- [Zai LAB (ZLAB US) Target Price Change]: Demonstrating Directionally Business Model to Profit
- [Zai LAB (ZLAB US) Earnings Review]: Pretty Much the Same…Maintain SELL
Trending Collections
More »Trending Insights
More »- Daiichi Sankyo Placement - US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well
- UK CPI Trend Extends Excess In July
- MV Australia Equal Weight Index Rebalance Preview: Three Potential Deletions in September
- Lynch Group (LGL AU): (Another) Clean Offer From TPG
- Korea's Dividend Narrative Is Back: Unpacking the DP's New Bill and Its Backstory
Top Unpaywalled Insights
More »- India-China Economic Relations: Navigating Massive Imbalances and Strategic Dependencies
- Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
- How to Own Lenovo at a Discount: BUY Legend Holdings Corp (3396 HK)
- Institutions Are Coming for Bitcoin — UTXO’s Loren Asmus Explains How
- Curator's Cut: Singapore Unlocks Value, India’s Jewellery Caution & Taiwan's Top ETF's Rebalance
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Zai Lab IPO: Experienced Team, Promising In-Licensing Drug Pipeline (Part 1)13 Sep 2017
- Okja: The Fight Between Netflix Vs. CJ CGV05 Jun 2017
- Netflix & Amazon Expand in Korea – Not a Coincidence20 Jan 2016
- Thoughts on Amazon –What Does Its Valuation Tells Us?01 Dec 2015
x